產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-ASAH2抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-ASAH2抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-ASAH2
Cat. Number:
Anti-ASAH2抗體KL-6021R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Hydrolyzes the sphingolipid Anti-ASAH2抗體ceramide into sphingosine and free fatty acid at an optimal pH of 6.5-8.5. Acts as a key regulator of sphingolipid signaling metabolites by generating sphingosine at the cell surface. Acts as a repressor of apoptosis both by reducing C16-ceramide, thereby preventing ceramide-induced apoptosis, and generating sphingosine, a precursor of the antiapoptotic factor sphingosine 1-phosphate. Probably involved in the digestion of dietary sphingolipids in intestine by acting as a key enzyme for the catabolism of dietary sphingolipids and regulating the levels of bioactive sphingolipid metabolites in the intestinal tract.
Also known as:
Acylsphingosine deacylase Anti-ASAH2抗體2; ASAH2; ASAH2_HUMAN; BCDase; hCD; HNAC1; LCDase; MGC129777; mitochondrial ceramidase; N acylsphingosine amidohydrolase (non lysosomal ceramidase) 2; N acylsphingosine amidohydrolase 2; N CDase; N-acylsphingosine amidohydrolase 2; N-CDase; NCDase; Neutral ceramidase soluble form; Non lysosomal ceramidase; Non-lysosomal ceramidase.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Rabbit, .
●
Immunogen: KLH conjugated Anti-ASAH2抗體synthetic peptide derived from human ASAH2.
●
Predicted Molecular Weight: 86kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions mustAnti-ASAH2抗體be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions mustAnti-ASAH2抗體be determined by the end user.
kl022Mu01 血管內(nèi)皮細(xì)胞蛋白C受體(PROCR)多克隆抗體 Polyclonal Antibody to Protein C Receptor, Endothelial (PROCR)
kl022Po01 血管內(nèi)皮細(xì)胞蛋白C受體(PROCR)多克隆抗體 Polyclonal Antibody to Protein C Receptor, Endothelial (PROCR)
kl022Ra01 血管內(nèi)皮細(xì)胞蛋白C受體(PROCR)多克隆抗體 Polyclonal Antibody to Protein C Receptor, Endothelial (PROCR)
kl024Bo01 ***腺來(lái)源血管內(nèi)皮生長(zhǎng)因子(EG-VEGF)多克隆抗體 Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl024Hu01 ***腺來(lái)源血管內(nèi)皮生長(zhǎng)因子(EG-VEGF)多克隆抗體 Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl024Mu01 ***腺來(lái)源血管內(nèi)皮生長(zhǎng)因子(EG-VEGF)多克隆抗體 Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl024Ra01 ***腺來(lái)源血管內(nèi)皮生長(zhǎng)因子(EG-VEGF)多克隆抗體 Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl025Bo01 嗜酸粒細(xì)胞趨化因子(ECF)多克隆抗體 Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Eq01 嗜酸粒細(xì)胞趨化因子(ECF)多克隆抗體 Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Gu01 嗜酸粒細(xì)胞趨化因子(ECF)多克隆抗體 Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
